RightEye LLC’s vision system designed to use eye tracking to aid patient care and improve vision performance has received 510(k) clearance from the US Food and Drug Administration, the Bethesda, Md-based company announces.

According to the company, the RightEye system has received FDA clearance for recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in patients.

The system, which includes RightEye EyeQ tests, reports, and training tools, has various applications, including:

  • Functional Vision Screening—RightEye functional vision test helps to quickly and objectively identify a host of functional vision issues that affect quality of life and automatically recommends computer-based exercises patients can do at home.
  • Reading Assessments—RightEye Reading EyeQ tracks reading proficiency in real time, identifying hidden vision issues associated with learning difficulties.
  • Sports Vision Assessment & Training—RightEye Sports Vision EyeQ identifies opportunities to strengthen performance-related aspects of vision, while Sports Vision Trainer offers personalized exercises to athletes looking to improve coordination and reaction times.
  • Brain Health—RightEye Brain Health EyeQ showcases the severity levels of vision skill problems and how this may relate to brain performance. It also provides computer-based vision exercises to help address oculomotor issues.

“RightEye is committed to providing innovative, proven eye-tracking solutions that empower doctors to differentiate and expand their practices while transforming the lives of their patients through improved health and wellness,” says Adam Gross, RightEye co-founder and CEO, in a media release.

“As we continue to pioneer the field of eye-tracking technology, we’ll advance the science and discover new solutions and applications that will benefit patients and doctors alike.”

For more information, visit RightEye LLC.

[Source(s): RightEye LLC, PR Newswire]